The US Food and Drug Administration (FDA) warned Indian generic drugmaker Glenmark Pharmaceuticals Limited for several good manufacturing practice (GMP) violations observed during an inspection of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results